The viral protein NSP1 acts as a ribosome gatekeeper for shutting down host translation and fostering SARS-CoV-2 translation.
NSP1
SARS-CoV-2
SL1
ribosome
translation
Journal
RNA (New York, N.Y.)
ISSN: 1469-9001
Titre abrégé: RNA
Pays: United States
ID NLM: 9509184
Informations de publication
Date de publication:
02 Dec 2020
02 Dec 2020
Historique:
received:
14
10
2020
accepted:
29
11
2020
entrez:
3
12
2020
pubmed:
4
12
2020
medline:
4
12
2020
Statut:
aheadofprint
Résumé
SARS-CoV-2 coronavirus is responsible for Covid-19 pandemic. In the early phase of infection, the single-strand positive RNA genome is translated into non-structural proteins (NSP). One of the first proteins produced during viral infection, NSP1, binds to the host ribosome and blocks the mRNA entry channel. This triggers translation inhibition of cellular translation. In spite of the presence of NSP1 on the ribosome, viral translation proceeds however. The molecular mechanism of the so-called viral evasion to NSP1 inhibition remains elusive. Here, we confirm that viral translation is maintained in the presence of NSP1. The evasion to NSP1-inhibition is mediated by the cis-acting RNA hairpin SL1 in the 5'UTR of SARS-CoV-2. NSP1-evasion can be transferred on a reporter transcript by SL1 transplantation. The apical part of SL1 is only required for viral translation. We show that NSP1 remains bound on the ribosome during viral translation. We suggest that the interaction between NSP1 and SL1 frees the mRNA accommodation channel while maintaining NSP1 bound to the ribosome. Thus, NSP1 acts as a ribosome gatekeeper, shutting down host translation or fostering SARS-CoV-2 translation depending on the presence of the SL1 5'UTR hairpin. SL1 is also present and necessary for translation of sub-genomic RNAs in the late phase of the infectious program. Consequently, therapeutic strategies targeting SL1 should affect viral translation at early and late stages of infection. Therefore, SL1 might be seen as a genuine 'Achille heel' of the virus.
Identifiants
pubmed: 33268501
pii: rna.078121.120
doi: 10.1261/rna.078121.120
pmc: PMC7901841
pii:
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Informations de copyright
Published by Cold Spring Harbor Laboratory Press for the RNA Society.
Références
J Virol. 2008 May;82(9):4471-9
pubmed: 18305050
Science. 2020 Sep 4;369(6508):1220-1227
pubmed: 32883864
Nat Struct Mol Biol. 2009 Nov;16(11):1134-40
pubmed: 19838190
Cell. 2020 Nov 25;183(5):1325-1339.e21
pubmed: 33080218
Curr Res Virol Sci. 2021;2:100007
pubmed: 34189489
Nat Struct Mol Biol. 2013 Feb;20(2):150-8
pubmed: 23262488
Nat Commun. 2020 Jul 30;11(1):3810
pubmed: 32733001
J Virol. 2007 Nov;81(21):11620-33
pubmed: 17715225
J Biochem. 1977 Oct;82(4):1103-8
pubmed: 200604
RNA. 2021 Sep;27(9):1025-1045
pubmed: 34127534
Annu Rev Virol. 2015 Nov;2(1):265-88
pubmed: 26958916
Nature. 2020 Mar;579(7798):270-273
pubmed: 32015507
JCI Insight. 2020 Nov 5;5(21):
pubmed: 33001861
Lancet. 2020 Feb 22;395(10224):565-574
pubmed: 32007145
Acta Pharm Sin B. 2020 May;10(5):766-788
pubmed: 32292689
PLoS Pathog. 2015 Oct 29;11(10):e1005215
pubmed: 26513244
Proteomics. 2015 Jul;15(14):2417-25
pubmed: 25914180
EMBO J. 1994 Aug 15;13(16):3882-91
pubmed: 8070415
J Virol. 2009 May;83(10):5282-8
pubmed: 19264783
Emerg Microbes Infect. 2020 Dec;9(1):221-236
pubmed: 31987001
RNA Biol. 2021 Apr;18(4):447-456
pubmed: 32965173
Cell. 2020 May 14;181(4):914-921.e10
pubmed: 32330414
J Virol. 1981 May;38(2):661-70
pubmed: 6165837
Biochem J. 2013 Feb 1;449(3):719-28
pubmed: 23140180
Proc Natl Acad Sci U S A. 2015 Jan 13;112(2):319-25
pubmed: 25516984
Nat Med. 2020 Apr;26(4):450-452
pubmed: 32284615
Mol Cell Biol. 1996 Dec;16(12):6859-69
pubmed: 8943341
J Virol. 2012 Dec;86(24):13598-608
pubmed: 23035226
J Virol. 2011 Jan;85(1):638-43
pubmed: 21047955
Adv Virus Res. 2006;66:193-292
pubmed: 16877062
Proc Natl Acad Sci U S A. 2006 Aug 22;103(34):12885-90
pubmed: 16912115
PLoS One. 2013 Apr 08;8(4):e61166
pubmed: 23593419
Adv Virus Res. 2016;96:165-192
pubmed: 27712623
Nat Commun. 2018 Nov 2;9(1):4600
pubmed: 30389913
Proc Natl Acad Sci U S A. 2021 Feb 9;118(6):
pubmed: 33479166
PLoS One. 2013 Apr 29;8(4):e62416
pubmed: 23658627
Mol Cell. 2019 Jun 20;74(6):1205-1214.e8
pubmed: 31080011
Nat Commun. 2015 Jul 08;6:7646
pubmed: 26155016
J Virol. 2012 Oct;86(20):11128-37
pubmed: 22855488
PLoS Pathog. 2007 Aug 10;3(8):e109
pubmed: 17696607
J Biol Chem. 2020 Sep 11;295(37):12910-12934
pubmed: 32661197
Cell Rep. 2020 Oct 6;33(1):108234
pubmed: 32979938
Nat Struct Mol Biol. 2020 Oct;27(10):959-966
pubmed: 32908316
RNA. 2020 Aug;26(8):937-959
pubmed: 32398273
J Virol. 2007 Apr;81(7):3151-61
pubmed: 17202208
Mol Cell. 2011 Jan 21;41(2):197-209
pubmed: 21255730
PLoS Pathog. 2011 Dec;7(12):e1002433
pubmed: 22174690
Bioinformatics. 2020 May 1;36(10):3148-3155
pubmed: 32096818
Nat Methods. 2009 May;6(5):343-5
pubmed: 19363495
EMBO J. 2015 Dec 14;34(24):3042-58
pubmed: 26604301
Nat Commun. 2016 Aug 24;7:12622
pubmed: 27554013
Science. 2020 Sep 4;369(6508):1249-1255
pubmed: 32680882